The vaccine, known as mRNA-4359, is currently in Phase 1 human trials, marking a significant step toward what could become a universal tool in the fight against cancer.

mRNA-based vaccine zaps tumours, enters human trials

mRNA-based vaccine designed to fight a wide array of solid tumours go for Phase 1 trial

5m read
TRENDING STORIES